Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
03 October 2019 | Story Ruan Bruwer | Photo Gallo Images
Lappies Labuschagne
Lappies Labuschagné got his first rugby contract with the Cheetahs after impressing for the Shimlas. He is now playing for Japan – the first Shimla to do so.

Former Shimla Lappies Labuschagné made his ex-coach Jaco Swanepoel proud when he was recently included in the Japan Rugby World Cup (RWC) squad.

Labuschagné, made his debut for Japan on 28 September as captain shortly before the tournament, which is currently under way there, then led Japan to a historic win over Ireland, the world’s fourth-ranked team.


Labuschagné has been playing his rugby in Japan since 2016. Previously, he played for the Shimlas between 2009 and 2012 and captained the team in 2012. At that time, Swanepoel was the head coach of the Shimlas. 

“I’m extremely glad that he got his chance to play in the World Cup, just to prove that he can compete at that level. It was wonderful to see the leadership we knew he had on Saturday,” Swanepoel said.

He believes Labuschagné was unlucky not to have played for the Springboks. In 2013, he was called up to the South African squad, but failed to force his way into the congested Springbok back row. 

“Subjectivity in team selection was the reason that he wasn’t considered. He deserved to be selected and he worked extremely hard. I don’t know of a player who worked harder than him. Nobody wanted to work out with him in the gymnasium, because he always put in extra effort. That made him special.”

Swanepoel describes Labuschagné as a “very special person”.

“Lappies the human being is perhaps a little bit better than Lappies the rugby player.”  

“Hopefully we can get a Japan rugby jersey from him to display in the Shimla room soon,” Swanepoel added.

Labuschagné isn’t the only former Kovsie at the RWC. In the Springbok management team, Rassie Erasmus (head coach), Jacques Nienaber (defence coach), and Vivian Verwant (physiotherapist) are also former Kovsies.


News Archive

Link between champagne bubbles and the UFS?
2012-11-16

Prof. Lodewyk Kock with an example of a front page of the publication FEMS Yeast Research, as adapted by F. Belliard, FEMS Central Office.
Photo: Leatitia Pienaar
15 November 2012

What is the link between the bubbles in champagne and breakthrough research being done at the Mayo Clinic in America? Nano research being done at our university.

Prof. Lodewyk Kock of Biotechnology says a human being consists of millions of minute cells that are invisible to the eye. The nano technology team at the UFS have developed a technique that allows researchers to look into such a cell, as well as other microorganisms. In this way, they can get an idea of what the cell’s “insides” look like.

The UFS team – consisting of Profs. Kock, Hendrik Swart (Physics), Pieter van Wyk (Centre for Microscopy), as well as Dr Chantel Swart (Biotechnology), Dr Carlien Pohl (Biotechnology) and Liza Coetsee (Physics) – were amazed to see that the inside of cells consist of a maze of small tunnels or blisters. Each tunnel is about 100 and more nanometres in diameter – about one ten thousandth of a millimetre – that weaves through the cells in a maze.

It was also found that these tunnels are the “lungs” of the cells. Academics doing research on yeast have had to sit up and take notice of the research being done at the UFS – to the extent that these “lungs” will appear on the front page of the highly acclaimed FEMS Yeast Research for all of 2013.

The Mayo Clinic, in particular, now wants to work with the UFS to study cancer cells in more detail in order to fight this disease, says Prof. Kock. The National Cancer Institute of America has also shown interest. This new nano technology for biology can assist in the study and development of nano medicine that can be used in the treatment of cancer and other life threatening diseases. Nano medicine uses nano metal participles that are up to one billionth of a metre in size.

Prof. Kock says laboratory tests indicate that nano medicine can improve the efficacy of anti-cancer medicine, which makes the treatment less toxic. “According to the Mayo Clinic team, nano particles are considered as a gold cartridge which is being fired directly at a cancer tumour. This is compared to fine shot that spreads through the body and also attacks healthy cells.”

“This accuracy implies that the chemotherapy dose can be lowered with fewer side effects. The Mayo Clinic found that one-tenth of the normal dosage is more effective against pancreas cancer in this way than the full dosage with a linkage to nano particles. According to the clinic, this nano medicine could also delay the spread of cancer,” says Prof. Kock.

The nano particles are used as messengers that convey anti-cancer treatment to cancer cells, where it then selectively kills the cancer cells. The transport and transfer of these medicines with regard to gold nano particles can be traced with the UFS’s nano technology to collect more information, especially where it works on the cell.

“With the new nano technology of the UFS, it is possible to do nano surgery on the cells by slicing the cells in nanometre thin slices while the working of the nano medicine is studied. In this way, it can be established if the nano medicine penetrates the cells or if it is only associated with the tiny tunnels,” says Prof. Kock.

And in champagne the small “lungs” are responsible for the bubbles. The same applies to beer and with this discovery a whole new reach field opens for scientists.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept